WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...
We prospectively surveyed for rectal colonization with vancomycin-resistant Enterococcus among 93 high-risk pediatric patients who were hospitalized at least 5 (median, 20) days. Fifty-two patients ...
Background: Our institution experienced an increase in the frequency of vancomycin-resistant enterococci (VRE) clinical isolates. Surveillance cultures upon hospital admission for patients at high ...
Antibiotic exposure and dirty hands were factors linked to nursing home contamination with the multidrug-resistant bacteria vancomycin-resistant Enterococci, or VRE, a new study finds. The report was ...
Theresa Wagner has studied enterococci and antibiotic resistance for several years. Here she is photographed in connection with another research project on enterococci. Creating new vaccines is one of ...
A drug-resistant strain of bacteria inhabiting hospital settings has evolved to utilize an antimicrobial genetic tool. Vancomycin-resistant Enterococcus faecium (VREfm) is responsible for many lethal ...
Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these ...
Antibiotic resistance is a major concern, particularly for immunocompromised patients, who are at greater risk of serious infections. Microbiota composition can help prevent pathogenic bacteria from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results